Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials
Title: | Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials |
---|---|
Authors: | Abiola Ibraheem, Colin Pillai, Ifeoma Okoye, J. Joshua Smith, Diane Reidy-Lagunes, Grace Macaulay, Olusegun Alatise |
Source: | JCO Global Oncology, Vol , Iss 7, Pp 1358-1363 (2021) |
Publisher Information: | American Society of Clinical Oncology, 2021. |
Publication Year: | 2021 |
Collection: | LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: | Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
More Details: | Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality rate is not comparable with that seen in westernized countries. To address global cancer disparity, globalization of cancer clinical trials to involve sub-Saharan Africa can serve as a platform where innovative targeted therapies can be made available to patients in the environ. In the 2019 African Organization for Research and Training in Cancer (AORTIC) conference held at Maputo, Mozambique, a group of clinical trialists spanning across multiple continents highlighted the opportunities in Africa for the conduct of cancer clinical trials. The secondary purpose of the meeting was to address the belief that Africa was incapable of conducting interventional cancer trials but showed the in-continent strengths, such as available capacities, trained local clinical trialists with clinical trial experiences, clinical trial consortia, local capabilities, mapping out logistics, ethical consideration, political will, real-time benefits of clinical trials to clinical practice, and future directions for trials. |
Document Type: | article |
File Description: | electronic resource |
Language: | English |
ISSN: | 2687-8941 |
Relation: | https://doaj.org/toc/2687-8941 |
DOI: | 10.1200/GO.21.00096 |
Access URL: | https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187 |
Accession Number: | edsdoj.5b0f95750cc344848f9b5b7a75b76187 |
Database: | Directory of Open Access Journals |
FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=26878941&ISBN=&volume=7&issue=7&date=20211201&spage=1358&pages=1358-1363&title=JCO Global Oncology&atitle=Cancer%20Clinical%20Trials%20in%20Africa%E2%80%94An%20Untapped%20Opportunity%3A%20Recommendations%20From%20AORTIC%202019%20Conference%20Special%20Interest%20Group%20in%20Clinical%20Trials&aulast=Abiola%20Ibraheem&id=DOI:10.1200/GO.21.00096 Name: Full Text Finder (for New FTF UI) (s8985755) Category: fullText Text: Find It @ SCU Libraries MouseOverText: Find It @ SCU Libraries – Url: https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187 Name: EDS - DOAJ (s8985755) Category: fullText Text: View record from DOAJ MouseOverText: View record from DOAJ |
---|---|
Header | DbId: edsdoj DbLabel: Directory of Open Access Journals An: edsdoj.5b0f95750cc344848f9b5b7a75b76187 RelevancyScore: 957 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 956.691040039063 |
IllustrationInfo | |
Items | – Name: Title Label: Title Group: Ti Data: Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Abiola+Ibraheem%22">Abiola Ibraheem</searchLink><br /><searchLink fieldCode="AR" term="%22Colin+Pillai%22">Colin Pillai</searchLink><br /><searchLink fieldCode="AR" term="%22Ifeoma+Okoye%22">Ifeoma Okoye</searchLink><br /><searchLink fieldCode="AR" term="%22J%2E+Joshua+Smith%22">J. Joshua Smith</searchLink><br /><searchLink fieldCode="AR" term="%22Diane+Reidy-Lagunes%22">Diane Reidy-Lagunes</searchLink><br /><searchLink fieldCode="AR" term="%22Grace+Macaulay%22">Grace Macaulay</searchLink><br /><searchLink fieldCode="AR" term="%22Olusegun+Alatise%22">Olusegun Alatise</searchLink> – Name: TitleSource Label: Source Group: Src Data: JCO Global Oncology, Vol , Iss 7, Pp 1358-1363 (2021) – Name: Publisher Label: Publisher Information Group: PubInfo Data: American Society of Clinical Oncology, 2021. – Name: DatePubCY Label: Publication Year Group: Date Data: 2021 – Name: Subset Label: Collection Group: HoldingsInfo Data: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22Neoplasms%2E+Tumors%2E+Oncology%2E+Including+cancer+and+carcinogens%22">Neoplasms. Tumors. Oncology. Including cancer and carcinogens</searchLink><br /><searchLink fieldCode="DE" term="%22RC254-282%22">RC254-282</searchLink> – Name: Abstract Label: Description Group: Ab Data: Cancer is now a formidable health care burden in sub-Saharan Africa (SSA) due to lifestyle westernization and longer life expectancy. The exponential increase in cancer incidence coupled with high mortality rate is not comparable with that seen in westernized countries. To address global cancer disparity, globalization of cancer clinical trials to involve sub-Saharan Africa can serve as a platform where innovative targeted therapies can be made available to patients in the environ. In the 2019 African Organization for Research and Training in Cancer (AORTIC) conference held at Maputo, Mozambique, a group of clinical trialists spanning across multiple continents highlighted the opportunities in Africa for the conduct of cancer clinical trials. The secondary purpose of the meeting was to address the belief that Africa was incapable of conducting interventional cancer trials but showed the in-continent strengths, such as available capacities, trained local clinical trialists with clinical trial experiences, clinical trial consortia, local capabilities, mapping out logistics, ethical consideration, political will, real-time benefits of clinical trials to clinical practice, and future directions for trials. – Name: TypeDocument Label: Document Type Group: TypDoc Data: article – Name: Format Label: File Description Group: SrcInfo Data: electronic resource – Name: Language Label: Language Group: Lang Data: English – Name: ISSN Label: ISSN Group: ISSN Data: 2687-8941 – Name: NoteTitleSource Label: Relation Group: SrcInfo Data: https://doaj.org/toc/2687-8941 – Name: DOI Label: DOI Group: ID Data: 10.1200/GO.21.00096 – Name: URL Label: Access URL Group: URL Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187" linkWindow="_blank">https://doaj.org/article/5b0f95750cc344848f9b5b7a75b76187</link> – Name: AN Label: Accession Number Group: ID Data: edsdoj.5b0f95750cc344848f9b5b7a75b76187 |
PLink | https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.5b0f95750cc344848f9b5b7a75b76187 |
RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1200/GO.21.00096 Languages: – Text: English PhysicalDescription: Pagination: PageCount: 6 StartPage: 1358 Subjects: – SubjectFull: Neoplasms. Tumors. Oncology. Including cancer and carcinogens Type: general – SubjectFull: RC254-282 Type: general Titles: – TitleFull: Cancer Clinical Trials in Africa—An Untapped Opportunity: Recommendations From AORTIC 2019 Conference Special Interest Group in Clinical Trials Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abiola Ibraheem – PersonEntity: Name: NameFull: Colin Pillai – PersonEntity: Name: NameFull: Ifeoma Okoye – PersonEntity: Name: NameFull: J. Joshua Smith – PersonEntity: Name: NameFull: Diane Reidy-Lagunes – PersonEntity: Name: NameFull: Grace Macaulay – PersonEntity: Name: NameFull: Olusegun Alatise IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 12 Type: published Y: 2021 Identifiers: – Type: issn-print Value: 26878941 Numbering: – Type: volume Value: 7 – Type: issue Value: 7 Titles: – TitleFull: JCO Global Oncology Type: main |
ResultId | 1 |